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Abstract
Background: The mechanism whereby bone activates resorptive behavior in osteoclasts, the cells that resorb bone, is
unknown. It is known that avb3 ligands are important, because blockade of avb3 receptor signaling inhibits bone resorption,
but this might be through inhibition of adhesion or migration rather than resorption itself. Nor is it known whether avb3
ligands are sufficient for resorption the consensus is that bone mineral is essential for the recognition of bone as the
substrate appropriate for resorption.
Methodology/Principal Findings: Vitronectin- but not fibronectin-coated coverslips induced murine osteoclasts to secrete
tartrate-resistant acid phosphatase, as they do on bone. Osteoclasts incubated on vitronectin, unlike fibronectin, formed
podosome belts on glass coverslips, and these were modulated by resorption-regulating cytokines. Podosome belts formed
on vitronectin-coated surfaces whether the substrates were rough or smooth, rigid or flexible. We developed a novel
approach whereby the substrate-apposed surface of cells can be visualized in the scanning electron microscope. With this
approach, supported by transmission electron microscopy, we found that osteoclasts on vitronectin-coated surfaces show
ruffled borders and clear zones characteristic of resorbing osteoclasts. Ruffles were obscured by a film if cells were
incubated in the cathepsin inhibitor E64, suggesting that removal of the film represents substrate-degrading behavior.
Analogously, osteoclasts formed resorption-like trails on vitronectin-coated substrates. Like bone resorption, these trails
were dependent upon resorbogenic cytokines and were inhibited by E64. Bone mineral induced actin rings and surface
excavation only if first coated with vitronectin. Fibronectin could not substitute in any of these activities, despite enabling
adhesion and cell spreading.
Conclusions/Significance: Our results show that ligands avb3 are not only necessary but sufficient for the induction of
resorptive behavior in osteoclasts; and suggest that bone is recognized through its affinity for these ligands, rather than by
its mechanical or topographical attributes, or through a putative ‘mineral receptor’.
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Introduction
The osteoclast is the cell that resorbs bone. It is formed through
the differentiation and fusion of mononuclear phagocyte precur-
sors in the presence of macrophage colony-stimulating factor (M-
CSF) and receptor activator of NFkB ligand (RANKL) [1,2]. Its
activity is normally closely integrated with that of bone-forming
osteoblasts, to enable the continual removal and replacement of
bone that occurs throughout life. Excessive or deficient osteoclastic
function leads to a number of bone diseases, including osteoporosis
and osteopetrosis.
Osteoclasts resorb bone by establishing a circle of close contact
between themselves and the bone surface, associated with the
appearance of a ring of actin, devoid of cytoplasmic organelles (the
‘clear zone’, or ‘sealing zone’). Vesicles containing proton pumps
and acid hydrolases are then inserted into the bone-apposed
membrane circumscribed by this ring, throwing the membrane
into convolutions: the ‘ruffled border’. Thus, a ‘resorptive
hemivacuole’ is formed between cell and bone, within which pro-
tons dissolve the mineral component of bone, and acid hydrolases,
predominantly cathepsin K, digest the organic matrix. Dissolved
products are transported in vesicles from the resorptive hemi-
vacuole and released at the opposite, basolateral surface [3,4].
This resorptive behavior is restricted to bone. Yet it remains
unknown how the osteoclast recognizes bone as appropriate for
resorption. Ligands for the vitronectin receptor, avb3 are essential,
because antibodies against avb3, and avb3-antagonists such as
echistatin and kistrin, potently inhibit bone resorption in vitro and
in vivo [5,6,7,8,9]. However, this might reflect a need for avb3
ligands for attachment or migration, because these are also
inhibited by avb3 antagonists [9,10]. Whether avb3 ligands also
activate resorptive behavior and whether they are sufficient for this
by themselves, has never been tested. There are alternative
explanations for the induction of resorptive behavior. It might
depend on some special characteristic of bone mineral: osteoclasts
resorb bone if the mineral is exposed on the bone surface, but do not
resorb bone that is unmineralized or has been demineralized
[11,12,13]. It has been proposed that activation of resorption occurs
through ligation of a ‘mineral receptor’ [14]. Another suggestion is
that osteoclasts are activated when they adhere to a rigid substrate,
whether the adhesive ligand is vitronectin, fibronectin or collagen
[15]. Another is that it is surface roughness that is recognized [16].
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The regulation of bone resorption is normally analyzed in
osteoclasts on bone. However, bone is a complex extracellular
matrix, comprising not only bone mineral and collagen, but many
other proteins of uncertain function. It would be very much easier
to distinguish the roles of adhesive ligands, bone mineral and other
factors in osteoclast activation if resorptive behavior could be
assessed on a substrate other than bone. There are several
correlates with resorption that could be used to enable such an
analysis.
One potential correlate is the induction of broad bands of F-
actin, the ‘actin rings’, which are formed by osteoclasts on bone
and have been shown to correlate with bone resorption [17,18,19]
However, osteoclasts do not form actin rings on glass/plastic
substrates. Intstead they form circumferential belts of podosomes,
dot-like foci of F-actin [19,20,21]. There is controversy as to the
relationship between podosome belts and actin rings. For example,
podosomes precede actin ring formation on bone, and may be
organs of attachment and migration rather than resorption [3];
and podosome belts have a considerably greater diameter than
actin rings; and consist of a discontinuous series of dots, rather
than a continuous ring, of F-actin. Some have interpreted the
differences between actin rings and podosome belts as indicating
that the mineral component of bone is unique in its ability to
induce actin rings, and is essential for resorptive behavior [22];
others point to the strong similarities in the molecular composition
of podosome belts and actin rings as evidence of their equivalence
[23,24]. Although podosome belts have been noted to be sup-
pressed by calcitonin [25] and increased by interleukin-1 (IL-1)
[26], the effects of resorption-regulating agents on podosome belts
have never been formally quantified. Thus, both the extent to
which podosome belts resemble actin rings, and the extent to
which possession of podosome belts signifies resorptive behavior,
are uncertain. We therefore elected to further test the relationship
of podosome belts to resorptive behavior in osteoclasts, before
using them as markers for this activity.
A second correlate is the secretion of tartrate-resistant acid
phosphatase (TRAP). TRAP is highly expressed by osteoclasts,
and has been shown to be secreted during bone resorption [27].
We therefore used TRAP secretion as a marker to detect
resorptive behavior on non-bone substrates.
A third correlate is the formation of the ‘ruffled borders’ and
‘clear zones’ that are characteristic of resorbing osteoclasts. To
detect these, we developed a novel approach whereby osteoclasts
could be incubated on substrates that could be dissolved after
incubation, so that the substrate-apposed surface of the osteoclast
could be inspected in the scanning electron microscope (SEM).
We found that podosome belt formation correlated closely with
resorptive behavior in osteoclasts. We therefore used this and the
other correlates of resorption to identify the characteristics of
substrates that are responsible for activation of resorptive behavior
in osteoclasts. We found that this activation was induced by first
coating substrates with vitronectin.
Results
Vitronectin induces TRAP release by osteoclasts
Osteoclasts were lifted into suspension, sedimented onto
coverslips that were uncoated, or coated with fibronectin or
vitronectin, and incubated for 5 hours in the resorption-inductive
cytokines M-CSF, RANKL and IL-1a [28]. After incubation,
TRAP was measured in the supernatants and lysate. Because
adhesion factors are required for osteoclasts to adhere to the
coverslips, in particular to enable adhesion of cells in the control
groups, the cells were all sedimented and subsequently incubated
in 2.5% FCS. We found (Fig. 1) that vitronectin caused a four-fold
increase in TRAP release compared to controls. In contrast,
fibronectin-coated coverslips suppressed TRAP release. This
suppression of TRAP release by fibronectin might be because
the cultures were incubated in 2.5% FCS, which contains
vitronectin. Thus, while control, uncoated coverslips are available
for coating by vitronectin from the FCS, this will be prevented in
those coverslips previously coated with fibronectin. We repeated
the TRAP secretion assay using coverslips coated with rat and
human fibronectin, through the concentration range 3-50 mg/ml.
TRAP secretion was similarly significantly suppressed below
control levels at all concentrations (data not shown).
Figure 1. Vitronectin induces TRAP release by osteoclasts. Bone marrow-derived osteoclasts were sedimented in MEM/2.5% FCS onto
coverslips that had been coated with the vitronectin or fibronectin at the concentrations shown. After 20 minutes, the coverslips were washed and
incubated for 5 hours in MEM containing 2.5% FCS, M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml), and with/without salmon calcitonin
(CT) (100 pg/ml). TRAP was then measured in the supernatant and lysate. n = 5 cultures per variable. A, B: *p,0.05 versus 0 group (A) or versus all
other groups (B); ANOVA plus Dunnett’s post-test. C: *p,0.05 versus no CT. ANOVA followed by Bonferroni post-test.
doi:10.1371/journal.pone.0012837.g001
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TRAP release by osteoclasts on bone is inhibited by calcitonin
[28]. If TRAP release on vitronectin-coated coverslips reflects
resorptive behavior, we would predict that it would be suppressed
by calcitonin. We found this to be the case (Fig. 1).
Podosome belt formation by osteoclasts is a marker for
resorptive behavior
Small numbers of podosome belts were observed in control
cultures to which no resorption-inductive cytokines had been
added (Fig. 2). In cultures to which osteoprotegerin (OPG), the
soluble decoy receptor for RANKL, was added no podosome belts
at all were observed. This suggests that the podosome belts seen in
control cultures were due to residual RANKL from the preceding
culture period. RANKL and IL-1a synergistically stimulated
podosome belt formation. Podosome belt formation was inhibited
by calcitonin (Fig. 2). These results are very similar to the effects of
the same agents on bone resorption [28].
The diameter of podosome belts formed by osteoclasts on glass
is considerably greater than that of actin rings on bone slices, and
this is a major difference between these actin structures. Unlike
glass coverslips, the cut surface of our bone slices is rough. There is
evidence that cells spread more extensively on smooth than on
rough substrates [29,30]. Therefore, to test whether substrate
roughness could account for the difference in circumference, we
cut slices from a block of Perspex using the saw used to cut bone
slices, and compared the actin structures that formed on the uncut
and cut surfaces of slices of Perspex with those of slices of bone cut
on the same saw. We found (Fig. 3) that the actin structures
formed on the rough (cut) Perspex were of smaller diameter than
those formed on the smooth (uncut) Perspex, and of greater width:
the rough surface caused the actin structures to resemble more
closely the actin rings formed on bone.
Vitronectin induces podosome belt formation in
osteoclasts
The above results show several parallels between podosome
belts and resorptive behavior. We therefore used podosome belts
as a marker to test the properties of substrates that are responsible
Figure 2. Podosome belt formation is regulated in a manner that parallels regulation of bone resorption. Bone marrow-derived
osteoclasts were sedimented in MEM/FCS onto glass coverslips. After 20minutes, the coverslips were washed and incubated for 5 hours in MEM/FCS
in M-CSF (50 ng/ml) plus the agents shown (A), or MEM/FCS in M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) with/without salmon
calcitonin (B). A: OPG: 500 ng/ml; IL-1a: 10 ng/ml. *p,0.05 versus 0; +p,0.05 versus 0+IL-1m, both ANOVA plus Dunnett’s post-test; a: p,0.05 versus
RANKL (30 ng/ml), ANOVA + Bonferroni post-test. n = 10 per variable. C-F: photomicrographs of phalloidin/DAPI preparations of cultures after
incubation as above in: C: 0; D: RANKL (30 ng/ml); E: RANKL (30 ng/ml) + IL-1a; F: calcitonin (100 pg/ml). Scale bars = 100 mm.
doi:10.1371/journal.pone.0012837.g002
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for the induction of resorptive behavior in osteoclasts. We found
that significant numbers of osteoclasts adhered to vitronectin-
coated glass coverslips at coating concentrations of 0.2 mg/ml and
above (Fig 4). Activation of these osteoclasts, as judged by the
percentage of osteoclasts demonstrating podosome belts, occurred
over a similar concentration range. Stimulation of podosome belts
by vitronectin appeared to be due primarily to an increase in the
number of belts produced. Stimulation of bone resorption shows a
similar pattern: it occurs through an increase in numbers, rather
than an increase in size, of excavations [31]. Fibronectin also
supported osteoclast adhesion, at similar coating concentrations.
However, in contrast to the effect of vitronectin, only very small
numbers of osteoclasts formed podosome belts. The number of
belts showed a bimodal response, with a maximum number of
belts seen at a concentration of 12.5 mg/ml. This experiment was
repeated using a second batch of bovine fibronectin, and using rat
and human fibronectin, with very similar results.
Vitronectin induces formation of ruffled border and clear
zone in osteoclasts
Osteoclasts were sedimented onto glass coverslips that had been
coated with nail-varnish and then with vitronectin or fibronectin.
After incubation, the cells were fixed. The disc of nail-varnish was
then peeled off the coverslip, inverted onto a glass slide, dissolved in
acetone, cells dehydrated in hexamethyldisilizane (HMDS), and
sputter-coated for scanning electron microscopy. In preliminary
experiments we tested the ability of nail-varnish to induce
podosome belts. Vitronectin-coated nail-varnish induced podosome
belts similar to those on vitronectin-coated glass, but no podosome
belts were seen on fibronectin-coated nail-varnish (Fig. 5).
The substrate-apposed surfaces of osteoclasts incubated on
vitronectin-coated substrates showed a central area of intense
membrane folds surrounded by a ring of flatter membrane, upon
which protrusions that appear likely to represent podosomes could
be seen (Fig. 5). The density of the folds varied from osteoclast to
osteoclast, and was generally greatest in the less spread cells.
Peripheral rings of podosome-like protrusions were always seen
surrounding areas that showed such folds. These appearances
seem to correspond to the actin rings and ruffled borders
characteristic of osteoclasts activated for resorption, and represent
strong evidence that vitronectin induces resorptive behavior in
osteoclasts. A full description of the morphology of the surface of
the cell responsible for the resorption of bone is beyond the scope
of the present work and will be submitted as a separate paper.
Osteoclasts incubated on fibronectin-coated substrates were well-
spread (Fig. 5), but in no instance were ruffles and podosome-like
structures observed beneath these cells. We noted that when
osteoclasts on vitronectin-coated substrates were incubated with the
cathepsin inhibitor E64, the film of protein often seen without E64
was more prominent, and obscured the undersurface of the cells
(Fig. 5). This is consistent with removal of the protein film in E64-
free cultures due to the action of secreted osteoclast cathepsins.
Membrane folds were not seen beneath osteoclasts incubated on
vitronectin-coated substrates in the presence of calcitonin. This
would be expected if the membrane folds reflect resorptive
behavior, since the ruffled borders of osteoclasts disappear in the
presence of calcitonin [32].
We also inspected osteoclasts after incubation on vitronectin-
coated substrates in the transmission electron microscope (TEM).
We found structures characteristic of ruffled borders and clear
zone in these cells (Fig. 6). No similar structures were seen in
osteoclasts that had been incubated on fibronectin.
Vitronectin induces formation of resorption-like trails by
osteoclasts on glass substrates
We analyzed further the hypothesis that digestion of the protein
film noted above reflects resorptive behavior. For this, osteoclasts
were sedimented onto vitronectin- or fibronectin-coated glass
coverslips, incubated with/without resorption-inducing cytokines
and protease inhibitors and examined in the SEM. We found that
many of osteoclasts incubated in resorption-stimulating cytokines
showed sharp-edged cleared areas behind and below their
retreating margins (Fig. 7). Such areas were not seen in association
with the macrophagic cells (smaller cells, with leaf-like rather than
filopodial dorsal membrane folds). These sharp-edged cleared
areas were reminiscent of the excavations seen behind the
retreating margin of osteoclasts incubated on bone [33]. In
contrast, cleared areas were rare in cultures from which RANKL
and IL-1a had been omitted, and those that were seen were
substantially smaller (Fig. 7). Formation of cleared areas was
inhibited by the cathepsin-inhibitor E64, but the metalloproteinase
inhibitor GM6001 had no apparent effect.
No cleared resorption-like trails were seen in association with
the retreating margin of osteoclasts incubated on fibronectin,
although the protein film had sometimes been removed in small
discontinuous foci adjacent to filopodia (Fig. 7).
Vitronectin coating of anorganic bone enables resorptive
behavior in osteoclasts
We found that osteoclasts did not adhere to anorganic bone that
had not been coated with adhesion factor. After coating with
vitronectin, many osteoclasts had adhered and many of these
Figure 3. The effect of substrate roughness on the morphology of podosome belts. Bone marrow-derived osteoclasts were sedimented in
MEM/BSA onto Perspex that had been coated with vitronectin (50 mg/ml), or bone slices. Osteoclasts were incubated for 5 hours in MEM/BSA with M-
CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) on uncut Perspex surfaces (smooth), or on the surface of Perspex cut with the same saw as
that used to prepare bone slices (rough). Phalloidin staining. Scale bars = 50 mm.
doi:10.1371/journal.pone.0012837.g003
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showed podosome belts (Fig. 8). Excavations could be seen in the
SEM after removal of cells. Osteoclasts adhered to fibronectin-
coated anorganic bone in similar numbers, and spread well, but
neither podosome belts nor excavations were formed by any of the
cells (Fig. 8).
We attempted to assess the undersurface of cells incubated on
slices of vitronectin-coated anorganic bone, by dissolving the bone
mineral in EDTA after fixation. However, the vitronectin had
percolated through the specimen, so that a three-dimensional
proteinaceous sponge-like cast of the anorganic bone slice
remained beneath the cells.
Flexible substrates can induce podosome belt formation
To test whether podosome belt formation requires a rigid
substrate, vitronectin was conjugated or coated onto PDMS sheets
or silicone rubber films respectively. We found that vitronectin
strongly induced podosome belts in both of these flexible substrates
(Fig. 9). Explanations for the differing size of podosome rings on
these two substrates might include differences in surface
roughness, which has been shown to influence the size of actin
rings [16], or differences in the density of vitronectin bound by the
two substrates.
Discussion
Although much has been learned over the last decade about
osteoclastic differentiation, far less is known of the mechanisms
through which bone induces resorption. Vitronectin receptor
ligands have been shown to be necessary for bone resorption
[5,6,7,8,9], but it is not known whether this reflects a requirement
for adhesion, cell spreading, migration and/or activation of bone
resorption. Nor is it known whether these ligands are sufficient to
activate resorption by osteoclasts. There are several alternative
possibilities. Activation of resorption might depend on some
special characteristic of bone mineral: osteoclasts resorb bone if the
mineral is exposed [12]; and it has been reported that actin rings,
which correlate with resorptive behavior, are formed by osteoclasts
only on bone or bone mineral [14]. An osteoclastic ‘mineral
receptor’ has been proposed [14]. Another suggestion is that
osteoclasts are activated when they detect a rigid substrate,
whether the adhesive ligand is vitronectin or fibronectin [15].
Another is that rough surfaces stimulate resorption [16]. To
analyze the mechanism of activation of resorptive behavior in
osteoclasts, our approach has been to incubate osteoclasts on
substrates other than bone, and to test the characteristics of the
substrate that lead to behavior expected of or observed in
resorbing osteoclasts.
For these experiments, we exploited a technique we have
recently developed whereby osteoclasts can be lifted into
suspension and can excavate bone within 3 hours of sedimentation
[28]. This enables us to test the response of mature osteoclasts to
defined substrates that have not been conditioned by the medium
used to generate osteoclasts, or by the osteoclasts themselves. We
used these suspensions first to test the ability of substrates to induce
secretion of TRAP. We chose this approach because TRAP is
released into the resorptive hemivacuole during bone resorption,
whence it is endocytosed and then released at the basolateral
surface of the cell [3]. TRAP secretion by osteoclasts sedimented
onto bone slices can be detected in the supernatant and correlates
with bone resorption [27]. Therefore, if substrates other than bone
are capable of inducing resorptive behavior, TRAP secretion
should occur. We observed potent stimulation of TRAP release by
osteoclasts incubated on vitronectin-coated glass coverslips. This
was abolished by the resorption-inhibiting hormone calcitonin.
These results are consistent with the hypothesis that vitronectin
activates resorptive behavior.
In contrast, fibronectin not only failed to induce, but actually
suppressed TRAP secretion. Small quantities of serum were used
in the assay, to enable adhesion of osteoclasts in the control group.
Because serum contains vitronectin, the experiment is in reality
comparing lower with higher vitronectin densities. From this
perspective, the explanation for inhibition of TRAP secretion by
fibronectin might be that fibronectin prevents vitronectin in the
serum from binding to the vitronectin receptor [34]. Alternatively,
the explanation might be that serum-derived vitronectin cannot
coat substrates already coated with fibronectin. We noted a similar
propensity of higher concentrations of fibronectin to suppress
‘basal’ podosome belt formation, in cultures to which no serum
had been added (Fig. 4). The explanation for this might be that
osteoclast-derived osteopontin, a potent avb3 ligand, might be
excluded from the substrate by fibronectin. A further intriguing
possible explanation for the results of both experiments is that
suppression of basal osteoclast activation is caused by the mutual
antagonism of signaling mechanisms demonstrated by integrins
[35], such that dominant signaling by higher densities of
fibronectin will suppress activation of the vitronectin receptor.
Whatever the explanation is, the differing ability of these ligands to
activate osteoclasts, despite very similar actions as adhesion factors,
is striking.
During bone resorption osteoclasts form a circumferential,
actin-rich ‘sealing zone’ or ‘clear zone’. This ‘actin ring’ has been
correlated with bone resorption [17,18]. Osteoclasts on non-
mineralized substrates do not show actin rings, but rather
circumferential belts of podosomes. The extent to which podo-
some belts resemble actin rings and to which possession of
podosome belts signifies resorptive behavior, is uncertain. It has
been claimed that the sealing zone on bone has a different three-
dimensional organization that is not derived from podosomes
[14,22]. However, it has also been suggested that isolated
podosomes fuse to give rise to a continuous sealing zone [19,36].
This view is supported by recent evidence that the sealing zone
consists of structural units clearly related to individual podosomes,
which differ primarily in density and inter-connectivity from the
podosome belts observed on other substrates [24].
We have identified two further similarities between podosome
belts and actin rings. First, podosome belts seem more closely
related to bone resorption than to cell spreading and migration.
Thus, the effects of regulators on podosome belts closely paralleled
their known effects on bone resorption. In contrast, neither M-
CSF, which induces migration and spreading but inhibits bone
resorption [37], nor fibronectin, which facilitated adhesion and
spreading, increased podosome belt formation.
Figure 4. Vitronectin induces podosome belt formation in osteoclasts. Bone marrow-derived osteoclasts were sedimented in MEM/BSA
onto glass coverslips that had been coated with the vitronectin or fibronectin at the concentrations shown. The coverslips were then washed and
incubated for 5 hours in MEM/BSA with M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) before fixation and staining for F-actin and DAPI.
Vitronectin (A–C) induced a dose-dependent increase in adhesion and podosome belt formation in osteoclasts. In contrast, fibronectin (D–F),
effectively induced adhesion of osteoclasts, but very few of the adherent cells developed podosome belts. *p,0.05 versus no adhesive ligand
(ANOVA + Dunnett’s). n = 20 fields (10x objective) per group. G, H: representative views of phalloidin/DAPI-stained osteoclasts incubated on
vitronectin (G) and fibronectin (H). Osteoclasts on fibronectin are devoid of podosome belts. Scale bars = 100 mm.
doi:10.1371/journal.pone.0012837.g004
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Second, we have found a possible explanation for a notable
difference between podosome belts and actin rings, namely their
circumference. Typically, the spreading of cells such as fibro-
blasts and epithelial cells is greater on smooth than on rough
surfaces [29,30]. To see whether the difference in diameter of
podosome belts could be attributed to surface roughness, we
compared podosome belts formed on a slice of Perspex cut with
our bone saw, with those formed on a smooth, uncut surface from
the same block. We found that the belts were of substantially
smaller diameter on the sawn surface, and more like actin rings
on bone. Thus, the lower density of podosome subunits on glass
[24] might reflect the greater spreading caused by the smooth
Figure 5. Vitronectin induces formation of ruffled border in osteoclasts. Glass coverslips were coated with nail-varnish. This was then
coated with vitronectin or fibronectin (50 mg/ml). Next, osteoclasts were incubated on this surface for 5 hours in MEM/BSA with M-CSF (50 ng/ml),
RANKL (30 ng/ml) and IL-1a (10 ng/ml), with/without the cathepsin inhibitor E64 (361027 M) or calcitonin (100 pg/ml). A,B: Phalloidin-stained
preparations after incubation on vitronectin (A) or fibronectin (B). In A, individual podosomes can be discerned within the circumferential belt of
podosomes. No podosomes are seen in the osteoclast that had been incubated on fibronectin. C–H: The discs of nail-varnish were separated from the
glass coverslip, inverted onto a glass slide, dissolved in acetone, dehydrated in HMDS, and sputter-coated with gold for visualization in the SEM. C,D:
undersurface of osteoclast incubated on vitronectin. The central area of the undersurface of the cell is filled with dense membrane folds, while the
circumference lacks folds, but shows raised foci likely to represent podosomes (arrows). Note residual film of protein attached to the cell periphery. D:
higher magnification of C. Note variation in density of membrane folds in the central area. E,F: Low and higher power view of undersurface of
osteoclast incubated on fibronectin. The surface is relatively featureless, and lacks the domain organization apparent after incubation on vitronectin.
G: The undersurface of osteoclasts was obscured by a protein film in cultures to which the cathepsin inhibitor E64 was added. Nevertheless, a
peripheral belt of raised, podosome-like structures can be discerned through the film. H: The undersurface of osteoclasts incubated with calcitonin
lacked membrane ruffles and podosome belts. Scale bars: A,B: 35 mm; C,F,H: 5 mm; D,G: 2 mm; E: 20 mm.
doi:10.1371/journal.pone.0012837.g005
Osteoclast Activation
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surface. Increased cell spreading would be expected to simulta-
neously increase podosome belt diameter and decrease podosome
density.
It has recently been shown that greater roughness in calcite
surfaces stabilizes and enlarges actin structures in osteoclasts [16].
This implies that surface roughness may play a role in the
Figure 6. Vitronectin induces ruffled borders and clear zones in osteoclasts. Osteoclasts were incubated for 5 hours in MEM/BSA with M-
CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) in 6-well plate wells coated with vitronectin or fibronectin (50 mg/ml), before raising into
suspension with a cell scraper and preparation for TEM. A: Osteoclast incubated on vitronectin shows a central area of ruffled border (arrowhead) and
a peripheral area free of organelles (‘clear zone’) (arrows). B, C: higher magnification of center (B) and lower portion (C) respectively of A, showing area
of ruffled border (B) and clear zone (C); D–F: Osteoclast incubated on fibronectin shows well-spread appearance, but the undersurface lacked the
membrane folds and clear zones seen in osteoclasts incubated on vitronectin. E and F are from central and lower portion of D respectively. Scale bars:
A, D: 5 mm; B, C, E, F: 1 mm.
doi:10.1371/journal.pone.0012837.g006
Figure 7. Vitronectin induces formation of resorption-like trails by osteoclasts on glass substrates. Osteoclasts were incubated for
5 hours in MEM/BSA with M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) (A, C–F), or M-CSF (B), together with the cathepsin inhibitor E64
(361027 M) (C) or GM6001 (1.361025 M) (D), on glass coverslips coated with vitronectin (A–D) or fibronectin (E, F) (50 mg/ml), before preparation for
SEM. A: Osteoclasts incubated in resorption-inducing cytokines on vitronectin show well-defined cleared areas at the retreating margins of the cells.
Macrophagic cells (some of which are identified by arrows, as the smaller cells, with leaf-like, rather than filopodial membrane folds) are not
associated with cleared areas. B: Only occasional, and small, cleared areas were seen in cultures to which resorption-inducing cytokines had not been
added. C: The formation of cleared areas was inhibited by the cysteine protease inhibitor E64. D: the MMP inhibitor GM6001 was without apparent
effect. E, F: No cleared areas were seen at the retreating pole of osteoclasts incubated on fibronectin, although there was evidence of focal
disturbance to the surface of the protein film in the region of filopodia. Scale bars = 50 mm.
doi:10.1371/journal.pone.0012837.g007
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regulation of resorption by osteoclasts. To the extent that we found
that rough surfaces made actin structures more closely resemble
those seen on bone, our data also support the notion that
resorption is enhanced on rough surfaces. However, we have also
presented strong evidence that activation of resorptive behavior
can occur on smooth, vitronectin-coated surfaces. Therefore, a
surface does not necessarily have to be rough to activate
osteoclasts.
In contrast to the observations of Geblinger et al, discussed
above, we found that a smooth surface enlarged actin structures.
There might be a bimodal relationship between actin structure
diameter and surface roughness: spreading by osteoblasts has been
found to be reduced both above and below an ‘optimal’ roughness
value [38]. In any event, our data show that the differing diameters
of actin structures on glass and bone do not necessarily imply that
podosome belts and actin rings are functionally distinct structures.
This supports the notion that podosome belts reflect activation of
resorptive behavior in osteoclasts.
We found that vitronectin induced podosome belt formation,
while fibronectin did not. While there have been several reports
documenting the ability of a variety of adhesion molecules to
enable osteoclastic adhesion to substrates, there has been only one
previous comparison of the ability of adhesion molecules to
activate actin ring formation. In this report, it was found that
fibronectin induces podosome belts [15], but in our experiments
neither rat, bovine nor human fibronectin did so, despite good
bioactivity as an adhesion and spreading factor. The cells used in
the previous report were mixed populations derived from co-
culture with osteoblasts, and used a substantially longer incubation
period. These differences would predispose to secretion of
vitronectin receptor ligands onto the glass surface, by osteoblastic
cells or by the osteoclasts themselves.
The contrast between the effects of vitronectin and fibronectin
on osteoclasts is remarkable. The osteoclast expresses both the
vitronectin receptor avb3 [34] and the fibronectin receptor a5b1
[39], and both vitronectin and fibronectin enabled osteoclasts to
attach to glass coverslips or bone mineral in the absence of serum,
and both facilitated cell spreading. Yet only vitronectin was able to
induce resorptive behavior. It has been established that bone
resorption is dependent upon c-Src [40,41,42], so that the likely
molecular basis for our observations is the demonstration that
c-Src binds selectively to b3 not b1 integrins, and that clustering of
b3 in vivo activates c-Src [43], while c-Src deficiency has no
detectable effects on fibronectin-receptor function [44].
During bone resorption, osteoclasts show a characteristic
‘ruffled border’, consisting of membrane folds, circumscribed
by a ‘clear zone’. Our TEM and SEM studies showed strong
morphological evidence, for the first time, of the formation of
ruffled borders and clear zones on a non-mineral substrate. Like
podosome belts and release of TRAP, these characteristic
structures were induced by vitronectin but not by fibronectin.
We noted in the SEM that substrates were covered by a protein
film. This film was more apparent under osteoclasts incubated in
the cathepsin inhibitor E64. Similar degradation of extracellular
matrix by osteoclasts has previously been reported [23]. This
matrix degradation might be a consequence of cell spreading or
migration, or it might reflect resorptive behavior. Our data favor
the latter: the film was digested by osteoclasts on vitronectin-
coated, but not fibronectin-coated glass coverslips, despite similar
cell spreading; and like bone resorption, digestion was less
pronounced in M-CSF (which stimulates osteoclast motility and
spreading but inhibits bone resorption [37]), than in resorption-
stimulators. The effects of proteinase inhibitors also suggest that
the trails are a consequence of resorptive behavior rather than
motility: degradation was inhibited by the cathepsin inhibitor but
not by the metalloproteinase inhibitor. These observations are
consistent with the hypothesis that vitronectin-coated substrates
induce resorptive behavior in osteoclasts.
The consensus has been that bone mineral is essential for
resorptive behavior in osteoclasts. Thus, if the mineral component
Figure 8. Vitronectin coating of anorganic bone enables podosome belt formation and resorption. Osteoclasts were incubated for
5 hours in MEM/BSA with M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) on slices of anorganic bone coated with vitronectin or
fibronectin (50 mg/ml). Podosome belts and excavations were frequently seen on vitronectin-coated anorganic bone slices (A, C), but were never seen
on fibronectin-coated anorganic bone slices (B, D). A, B: Phalloidin/DAPI staining; C, D: SEM images. Scale bars A–C: 25 mm; D: 50 mm.
doi:10.1371/journal.pone.0012837.g008
Osteoclast Activation
PLoS ONE | www.plosone.org 9 September 2010 | Volume 5 | Issue 9 | e12837
of bone is removed, neither bone resorption nor actin rings are
observed [12,15]. In contrast, osteoclasts resorb bone from which
the organic component has been removed (bone mineral), and
some other mineral substrates [12,14,45]. These observations have
led to the suggestion that osteoclasts recognize bone through a
putative ‘mineral receptor’. It should be noted though that
previous experiments included serum in the incubation medium.
In the present experiments we used serum-free medium. We found
without serum osteoclasts did not adhere to bone mineral, and
while both vitronectin and fibronectin enabled adhesion, only
vitronectin induced podosome belts and substrate resorption.
Thus, vitronectin can act at least as a cofactor (with bone mineral)
for induction of resorption by osteoclasts. However, we also found
that coating non-mineral substrates with vitronectin induces
TRAP release, podosome belt formation, protein coat degradation
and ruffled border formation. This shows that it is the vitronectin,
rather than the bone mineral, that is necessary for induction of
resorptive behavior. Bone mineral appears to act, like glass
coverslips, through its ability to immobilize vitronectin receptor
ligands.
Vitronectin receptor ligands such as osteopontin and thrombos-
pondin are highly expressed by bone cells and have a strong
affinity for bone mineral through a multiphosphorylated motif
[46,47,48,49]. Such ligands, incorporated in bone during bone
formation, might activate osteoclasts when bone mineral is ex-
posed by osteoblastic cells [50]. Alternatively or additionally, activa-
tion might follow binding of osteopontin or bone sialoprotein,
which are known to be expressed by osteoclasts [51,52,53,54], to
freshly-exposed bone mineral, or binding of avb3 ligands secreted
by osteoclast-regulatory osteoblastic cells independently of bone
Figure 9. Flexible substrates can induce podosome belt formation. Osteoclasts were incubated for 5 hours in MEM/BSA with M-CSF (50 ng/
ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml) on PDMS sheets or silicone films coated with vitronectin or fibronectin (50 mg/ml). A,B: Osteoclasts
adhered to fibronectin-coated PDMS sheets in large numbers, but podosome belts were very rare. In contrast, a similar proportion of osteoclasts
formed podosome belts on vitronectin-coated PDMS sheets to our previous experience using rigid substrates. *p,0.05 versus control (ANOVA +
Dunnett’s); n = 10 per group. C–F: Representative views of osteoclasts on fibronectin-coated silicone film (C) or PDMS sheet (E)0; and vitronectin-
coated silicone film (D) or PDMS sheet (F). Note that osteoclasts on fibronectin-coated substrates are well-spread but lack podosome belts. Phalloidin/
DAPI staining. Scale bars: C,D: 50 mm; E,F: 100 mm.
doi:10.1371/journal.pone.0012837.g009
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formation, or vitronectin from serum, in which it is present at
between 300–700 mg/ml [55,56]. Osteoblastic cells are known to
be crucial for the regulation of osteoclast formation and the rate of
their resorptive activity. The above observations provide a novel
mechanism through which osteoblastic cells could extend their
ability to regulate osteoclasts to include the induction and
localization of resorption, by exposing mineral onto the bone
surface through secretion of interstitial collagenase [57].
Glass and bone share not only the ability to adsorb vitronectin,
but structural rigidity. It has been suggested that structural rigidity
is what distinguishes tissues that are resorbed from those that are
not. This might explain why demineralized bone does not induce
bone resorption or podosome belts [12,15]. Our observations do
not support this model. We found that, unlike vitronectin,
fibronectin coating of rigid substrates does not induce resorptive
behavior despite a similar capacity to induce adhesion and
spreading. This suggests that high substrate rigidity is not sufficient
to induce resorptive behavior. Further, we noted that flexible
silicone and PDMS sheets induced podosome belts in osteoclasts,
when coated with vitronectin. Thus, a rigid substrate is neither
necessary nor sufficient for the induction of resorptive behavior. In
fact, vitronectin appears to be capable of recapitulation of the
osteoclast-bone interaction: it is sufficient to induce osteoclasts to
form podosome belts, to secrete enzymes, to undertake substrate
digestion, and to form clear zones and ruffled borders.
Vitronectin receptor ligands have long been known to be
necessary for bone resorption [58], but the finding that they are
sufficient is novel. Moreover, it has not been previously deter-
mined whether vitronectin is needed for activation of resorption,
and/or for other functions essential for bone resorption to occur,
such as cell adhesion. It has been shown in many elegant
molecular biological studies that the vitronectin receptor partic-
ipates in cell signaling in osteoclasts [51,52,53]. Our experiments
should facilitate such studies by enabling a distinction between
those signals that mediate adhesion and cell spreading and those
that mediate the induction of bone resorption.
We have found a strong correlation between podosome belts
and other correlates of resorptive behavior, and this makes them a
reliable indicator of resorptive activity in osteoclasts. We also show
that avb3 ligands are not only necessary but sufficient for the
induction of resorptive behavior in osteoclasts; and that it is these
ligands, rather than bone itself, that induces resorption; and that
bone is recognized due to the high affinity of bone mineral for
these ligands combined with the specific signals generated by
ligation of avb3, rather than by its mechanical or topographical
attributes or through a putative ‘mineral receptor’. Last, we
present a novel approach whereby the substrate-apposed surface
of not only osteoclasts but any substrate-adherent cell can be
directly inspected in the SEM.
Materials and Methods
Ethics Statement
Mice were killed by a Schedule 1 method, according to Home
Office (UK) guidelines. This study did not require approval by an
ethics committee because no experiments involving live animals
were performed.
Media and reagents
Cells were incubated in minimum essential medium (MEM)
with Earle’s salts, supplemented with 10% fetal calf serum (FCS),
2 mM glutamine, 100 IU/ml benzylpenicillin and 100 mg/ml
streptomycin (all Sigma, Poole, Dorset, UK) for osteoclast
formation. For assays, 10% FCS was replaced with 2.5% FCS
for TRAP release, or 0.1% BSA (Sigma) for all other experiments,
unless stated otherwise. Recombinant human M-CSF, recombi-
nant human OPG and recombinant mouse RANKL were
purchased from PeproTech EC (London, UK). Recombinant
mouse IL-1a and purified human TGF-b1 were obtained from R
& D Systems (Abingdon, Oxon., UK). GM6001 was from Merck
Chemicals Ltd. (Nottingham, UK). All other reagents were
provided by Sigma, unless otherwise stated. Incubations were
performed at 37uC in 5% CO2 in humidified air, unless stated
otherwise.
Preparation of vitronectin- and fibronectin-coated
substrates
Slices of bovine cortical bone were prepared as previously
described [31]. These were rendered anorganic by treating with
sodium hypochlorite solution (10–15%) for 8 days, followed by
extensive washing in water.
Perspex slices (ca. 1 cm2) were prepared from a block of Perspex
by cutting slices in the same low-speed saw as was used to prepare
bone slices. Slices cut from the uncut surface of the block were
used as smooth substrates and compared with the cut surface of
deeper slices.
Thirteen mm diameter glass coverslips were coated with a film of
clear nail-varnish (Rimmel, London, UK) using a Pasteur pipette.
Polydimethylsiloxane (PDMS) rubber sheets were prepared by
casting ELASTOSIL RT 601 (Wacker Chemie AG, Munich,
Germany). The two components were mixed according to the
manufacturer’s instructions and 0.5 ml added to wells of 12-well
plates (BD Biosciences, Oxford, UK), before being de-gassed using
a vacuum pump for 30 minutes. The silicone rubber was allowed
to cure for 3 days at room temperature.
Flexible silicone rubber films were prepared by adding 25 ml
silicon DC-200 to the centre of 6-well plate wells (Greiner Bio-
One, Stonehouse, Gloucestershire, UK) and allowing to spread for
18 h. The surface of the silicone was then polymerized by sputter
coating with gold (20 mA; 20 seconds).
To coat the substrates, vitronectin or fibronectin (both bovine
unless stated otherwise) were dissolved in water. Fifty ml was placed
on the surface of 6 mm diameter coverslips or the centre of the
silicone films, and 300 ml on 13 mm diameter glass coverslips,
Perspex or anorganic bone slices (ca. 1 cm2), and dried overnight
at room temperature in a tissue culture hood.
Vitronectin or fibronectin were covalently bound to the surface of
PDMS sheets using sulfo-SANPAH (Thermo Scientific, Basing-
stoke, Hampshire, UK). Briefly, 1 ml of 1 mM sulfo-SANPAH was
added to wells containing the sheets and bound to the surface of the
silicone rubber by exposure to UV light (365 nM, 15 minutes) in a
UV cross-linker (model CL-E508; UVITEC, Cambridge, UK). The
sulfo-SANPAH was then removed, the PDMS sheets washed with
PBS, fresh sulfo-SANPAH added and the photoactivation process
repeated. After extensive washing, 1.5 ml of vitronectin or
fibronectin (both 30 mg/ml PBS) were added onto the PDMS
sheets and the proteins allowed to bind for 18 hours at room
temperature. The sheets were washed with PBS and 1.5 ml MEM/
BSA added to wells prior to cell addition.
Preparation of osteoclast suspensions
MF1 mice (4–8 weeks old) were killed by cervical dislocation.
Femora and tibiae were aseptically removed and dissected free of
adherent soft tissue. The bone ends were removed and the marrow
cavity flushed out into a petri dish by slowly injecting PBS at one
end of the bone using a sterile 25-gauge needle. The bone marrow
suspension was passed repeatedly through a 21-gauge needle to
obtain a single cell suspension. Bone marrow cells were then
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washed, resuspended in MEM/FCS and incubated at a density of
36105 cells/ml for 24 hours in a 175-cm2 flask (Greiner Bio-One)
with M-CSF (5 ng/ml), to deplete the cell preparations of stromal
cells. Non-adherent cells were collected by centrifugation and
added to 90 mm diameter cell culture dishes (Greiner Bio-One) in
MEM/FCS, containing M-CSF (50 ng/ml), RANKL (30 ng/ml)
and TGF-b (0.1 ng/ml) (7.26106 cells in 25 ml for each dish).
Cultures were incubated for 5 days, by which time osteoclast
formation was maximal. Cells were fed every 2–3 days by
replacing 15 ml of culture medium with an equal volume of fresh
medium and cytokines.
After formation of osteoclasts on the base of a 90 mm-diameter
plastic tissue culture dish, osteoclasts were scraped from the dish into
suspension as previously described [28]. To do this, the medium was
removed and the cell layer washed 3 times with PBS without
calcium and magnesium. Six ml of 0.02% EDTA was added to the
dish and cells incubated for 20 minutes at room temperature. The
EDTA was then removed from the dish and replaced with 3.6 ml of
calcium/magnesium-free PBS. A cell scraper (Greiner Bio-One)
was used to scrape the cells into the PBS, and the resulting cell
suspension was agitated using a pipette to ensure uniform cell
dispersal, and added to cultures as described below.
Measurement of release of TRAP
Vitronectin- or fibronectin-coated or uncoated 6 mm diameter
coverslips were placed in the wells of a 96-well plate (Greiner Bio-
One) and 75 ml MEM/2.5% FCS was added to each well. Seventy
five ml of the osteoclast suspension was then added to each well.
Cells were allowed sediment for 20 minutes at 37uC before the
coverslips were washed and transferred to fresh 96-well plate wells
and incubated for 5 hours in 100 ml MEM/2.5% FCS in M-CSF
(50 ng/ml), RANKL (30 ng/ml) and IL-1a (10 ng/ml).
After incubation of cells for 5 hours on coverslips, supernatants
were removed for measurement of enzyme release. Cell lysates, for
assessment of enzyme remaining in cells, were then prepared:
coverslips were washed in PBS, transferred to fresh 96-well plate
wells and incubated in 100 ml 0.1% Triton X-100 in water (v/v)
for 10 minutes. TRAP enzyme activity was measured by the
conversion of p-nitrophenyl phosphate to p-nitrophenol in the
presence of sodium tartrate. Eighty ml of each supernatant or
lysate, diluted appropriately, was added to 96-well plate wells
containing 80 ml 0.09 M citrate buffer with 20 mM phosphatase
substrate and 80 mM tartaric acid and incubated at room
temperature for 40 minutes. The reaction was stopped by addition
of 40 ml of 0.5 M sodium hydroxide. Optical absorbance was
measured at 405 nm on an Opsys MR plate reader (Thermo
Scientific) against a standard curve of p-nitrophenol. The extent of
enzyme activity released into the supernatant as a percentage of
total enzyme activity in the supernatant and lysate combined was
calculated for each culture assayed.
Assessment of podosome belts in osteoclasts
Vitronectin- or fibronectin-coated or uncoated bone, 13 mm
diameter glass and Perspex substrates were placed in the wells of a
24-well-plate (Greiner Bio-One) containing 450 ml MEM/BSA or
MEM/FCS. Four hundred and fifty ml of the osteoclast suspension
was added to each well. Cells were allowed sediment for 20 min at
37uC before the substrates were washed and transferred to fresh
24-well plate wells and incubated for 5 h in 1 ml MEM/BSA or
MEM/FCS with M-CSF (50 ng/ml), with/without RANKL (30
or 100 ng/ml), IL-1a (10 ng/ml), OPG (500 ng/ml) and salmon
calcitonin (0.1–1000 pg/ml).
Two or 1.5 ml MEM/BSA were added to wells containing
silicone rubber films or PDMS sheets respectively and an equal
volume of osteoclast cell suspension added. Cells were allowed to
sediment for 20 minutes then substrates washed 3 times with PBS.
Cells were incubated 5 hours in 2 ml (films) or 1.5 ml (sheets)
MEM/BSA with M-CSF (50 ng/ml), RANKL (30 ng/ml) and IL-
1a (10 ng/ml).
After incubation for 5 hours on these substrates, the cultures
were fixed in 10% formalin and cells permeabilized with 0.1%
Triton X-100 for 5 minutes. Cells were then incubated in 1 mg/ml
FITC-conjugated phalloidin for 45 minutes at 37uC, washed and
mounted in VECTORSHIELD mounting medium with DAPI
(Vector Laboratories, Peterborough, UK).
Podosome belts were counted by photographing a minimum of
10 fields/replicate using a x10 objective on a Zeiss Axiovert
200 M microscope (Carl Zeiss, Welwyn Garden City, Hertford-
shire, UK) using a Zeiss Axiocam MRC5 camera and Zeiss
Axiovision 4.6 software. The number of osteoclasts, the percentage
of osteoclasts with podosome belts and the total area within
podosome belts were quantified for each photograph.
Assessment of osteoclast morphology in the SEM
Nail-varnish coated coverslips that had been coated with
vitronectin or fibronectin were placed in 24-well plates.
Osteoclast suspension was added as above, and incubated for
5 hours. The coverslips were then washed, and fixed in 4%
glutaraldehyde in 0.2 M sodium cacodylate buffer for 18 hours.
After fixation the circle of nail-varnish could readily be detached
from the glass coverslip, and it was inverted onto a glass
microscope slide. The nail-varnish was dissolved and the cells
dehydrated in an acetone series (30, 50, 70, 90, 100%; 5 min
each). Care was taken to avoid allowing the circle dry out. After 5
minutes in 100% acetone, HMDS was added gently to the cells,
and after a further 5 minutes the slide was drained and allowed
to dry. The glass slide was cut to a square, attached to a
stub, sputter-coated with gold and examined in a Cambridge
Stereoscan 360 SEM (Cambridge Instrument Company, Cam-
bridge, UK).
Assessment of osteoclast morphology in the TEM
Six-well plate wells were coated with vitronectin or fibronectin
(both 1.5 ml/well at 30 mg/ml) and 2 ml MEM/BSA added to
wells after coating prior to cell addition. Two ml of osteoclast cell
suspension was then added to the wells and cells sedimented and
incubated as above. After incubation, cells were fixed in 4%
glutaraldehyde in 0.2 M cacodylate buffer for 18 hours. The cell
layers were then washed 3 times with PBS, scraped into 1 ml of
PBS and then processed for TEM.
Assessment of resorption-like trails by osteoclasts
Vitronectin- or fibronectin-coated glass coverslips were placed
in 24-well plate wells with 450 ml MEM/BSA and 450 ml cell
suspension, diluted 1:4 with PBS, added as above. After cell
sedimentation, the coverslips were incubated 5 hours in 1 ml
MEM/BSA with M-CSF (50 ng/ml) with/without RANKL
(30 ng/ml), IL-1a (10 ng/ml), E64 (361027 M) and GM6001
(13 mM). After incubation, the coverslips were washed in PBS and
fixed in 4% glutaraldehyde 18 hours. Coverslips were then washed
in PBS and cells prepared for SEM by dehydrating through an
acetone series and HMDS, and sputter coating as above.
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